Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06409156 · ClinicalTrials.gov registry record · NA
EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery
A NA study of Open Abdominal Surgery, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06409156 is a NA study of Open Abdominal Surgery that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06409156, a NA study of Open Abdominal Surgery, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a single-center, assessor blinded, randomized control trial to compare the efficacy of external oblique fascial plane (EOIFP) block versus Oblique Subcostal Transversus Abdominis Plane (OSTAP) block for patients undergoing open upper abdominal surgery at Cleveland Clinic Main Campus.
Conditions Studied
Interventions
- PROCEDURE Oblique Subcostal Transversus Abdominis Plane Block
- PROCEDURE External Oblique Intercostal Fascial Plane block
Study Locations (1)
Ohio
- Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-06-26 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06409156
The ClinicalTrials.gov registry entry for NCT06409156 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Abdominal Surgery appearing as the primary indexed condition, and to 2 interventions - of which Oblique Subcostal Transversus Abdominis Plane Block is the first listed.
NCT06409156 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06409156 about?
NCT06409156 is a clinical study titled "EOIFP Block Versus OSTAP Block for Upper Abdominal Surgery". The investigators propose a single-center, assessor blinded, randomized control trial to compare the efficacy of external oblique fascial plane (EOIFP) block versus Oblique Subcostal Transversus Abdominis Plane (OSTAP) block for patients undergoing open upper abdominal surgery at Cleveland Clinic Ma...
What is the current status of trial NCT06409156?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-06-26. Estimated completion is 2026-12-31.
What conditions does trial NCT06409156 study?
This clinical trial studies the following conditions: Open Abdominal Surgery.
What interventions are being tested in trial NCT06409156?
The interventions under investigation include: Oblique Subcostal Transversus Abdominis Plane Block (PROCEDURE), External Oblique Intercostal Fascial Plane block (PROCEDURE).
Who is sponsoring clinical trial NCT06409156?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06409156 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.